Correlation Between IDEXX Laboratories and Aclaris Therapeutics

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both IDEXX Laboratories and Aclaris Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining IDEXX Laboratories and Aclaris Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between IDEXX Laboratories and Aclaris Therapeutics, you can compare the effects of market volatilities on IDEXX Laboratories and Aclaris Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in IDEXX Laboratories with a short position of Aclaris Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of IDEXX Laboratories and Aclaris Therapeutics.

Diversification Opportunities for IDEXX Laboratories and Aclaris Therapeutics

-0.75
  Correlation Coefficient

Pay attention - limited upside

The 3 months correlation between IDEXX and Aclaris is -0.75. Overlapping area represents the amount of risk that can be diversified away by holding IDEXX Laboratories and Aclaris Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Aclaris Therapeutics and IDEXX Laboratories is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on IDEXX Laboratories are associated (or correlated) with Aclaris Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Aclaris Therapeutics has no effect on the direction of IDEXX Laboratories i.e., IDEXX Laboratories and Aclaris Therapeutics go up and down completely randomly.

Pair Corralation between IDEXX Laboratories and Aclaris Therapeutics

Given the investment horizon of 90 days IDEXX Laboratories is expected to generate 5.95 times less return on investment than Aclaris Therapeutics. But when comparing it to its historical volatility, IDEXX Laboratories is 3.82 times less risky than Aclaris Therapeutics. It trades about 0.01 of its potential returns per unit of risk. Aclaris Therapeutics is currently generating about 0.02 of returns per unit of risk over similar time horizon. If you would invest  1,592  in Aclaris Therapeutics on August 27, 2024 and sell it today you would lose (1,212) from holding Aclaris Therapeutics or give up 76.13% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthWeak
Accuracy100.0%
ValuesDaily Returns

IDEXX Laboratories  vs.  Aclaris Therapeutics

 Performance 
       Timeline  
IDEXX Laboratories 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days IDEXX Laboratories has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of uncertain performance in the last few months, the Stock's basic indicators remain fairly strong which may send shares a bit higher in December 2024. The current disturbance may also be a sign of long term up-swing for the company investors.
Aclaris Therapeutics 

Risk-Adjusted Performance

17 of 100

 
Weak
 
Strong
Solid
Compared to the overall equity markets, risk-adjusted returns on investments in Aclaris Therapeutics are ranked lower than 17 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively fragile basic indicators, Aclaris Therapeutics unveiled solid returns over the last few months and may actually be approaching a breakup point.

IDEXX Laboratories and Aclaris Therapeutics Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with IDEXX Laboratories and Aclaris Therapeutics

The main advantage of trading using opposite IDEXX Laboratories and Aclaris Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if IDEXX Laboratories position performs unexpectedly, Aclaris Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Aclaris Therapeutics will offset losses from the drop in Aclaris Therapeutics' long position.
The idea behind IDEXX Laboratories and Aclaris Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Global Correlations module to find global opportunities by holding instruments from different markets.

Other Complementary Tools

Money Flow Index
Determine momentum by analyzing Money Flow Index and other technical indicators
Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
Bonds Directory
Find actively traded corporate debentures issued by US companies
My Watchlist Analysis
Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like
Piotroski F Score
Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals